Study of LX4211 in Subjects With Type 2 Diabetes Mellitus

NCT00962065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: LX4211 Low Dose
DRUG: LX4211 High Dose
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals